SHANGHAI, Dec 8 (Reuters) – Eli Lilly and Co.’s popular drug Mounjaro will be added to China’s state-run health insurance scheme from Jan. 1 for patients with type 2 diabetes, the National Healthcare ...

Only one-third of insurers in China provide mental health services, despite rising demand Fifty percent of insurers see personalisation as key to the success of health and wellbeing programs The ...

Nineteen novel drugs have been selected for inclusion in the first iteration of China's Commercial Health Insurance Innovative Drug Catalogue, portending potential access benefits as the program gains ...

Insurer to increase stock investment against low-yield environment, co-CEO says First-half net profit down 8.8%, investment income sinks 30% Number of retail customers rises 1.8% NBV of life and ...

Insurers continue to face weak domestic demand, the agency said. China’s non-life insurance sector is expected to remain stable over the next year, according to AM Best. The agency kept its outlook ...